Trial Profile
Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2022
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy; Partial epilepsies
- Focus Therapeutic Use
- 25 Aug 2020 Planned End Date changed from 1 Jul 2019 to 1 Jul 2021.
- 25 Aug 2020 Planned primary completion date changed from 1 Mar 2019 to 1 Jul 2021.
- 13 Mar 2018 New trial record